Search Results - "Matovu, Joshua"

Relating CYP2B6 genotype and efavirenz resistance among post-partum women living with HIV with high viremia in Uganda: a nested cross-sectional study by Buzibye, Allan, Wools-Kaloustian, Kara, Olagunju, Adeniyi, Twinomuhwezi, Ellon, Yiannoutsos, Constantin, Owen, Andrew, Neary, Megan, Matovu, Joshua, Banturaki, Grace, Castelnuovo, Barbara, Lamorde, Mohammed, Khoo, Saye, Waitt, Catriona, Kiragga, Agnes

“…We investigated the association between CYP2B6 polymorphisms and efavirenz drug resistance among women living with HIV who started on antiretroviral therapy…”
Get full text

Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda by Omali, Denis, Buzibye, Allan, Kwizera, Richard, Byakika-Kibwika, Pauline, Namakula, Rhoda, Matovu, Joshua, Mbabazi, Olive, Mande, Emmanuel, Sekaggya-Wiltshire, Christine, Nakanjako, Damalie, Gutteck, Ursula, McAdam, Keith, Easterbrook, Philippa, Kambugu, Andrew, Fehr, Jan, Castelnuovo, Barbara, Manabe, Yukari C., Lamorde, Mohammed, Mueller, Daniel, Merry, Concepta

“…Background: Research and clinical use of clinical pharmacology laboratories are limited in low- and middle-income countries. We describe our experience in…”
Get full text

A portable magnetofluidic platform for detecting sexually transmitted infections and antimicrobial susceptibility by Trick, Alexander Y, Melendez, Johan H, Chen, Fan-En, Chen, Liben, Onzia, Annet, Zawedde, Aidah, Nakku-Joloba, Edith, Kyambadde, Peter, Mande, Emmanuel, Matovu, Joshua, Atuheirwe, Maxine, Kwizera, Richard, Gilliams, Elizabeth A, Hsieh, Yu-Hsiang, Gaydos, Charlotte A, Manabe, Yukari C, Hamill, Matthew M, Wang, Tza-Huei

“…Effective treatment of sexually transmitted infections (STIs) is limited by diagnostics that cannot deliver results rapidly while the patient is still in the…”
Get more information

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations by Sekaggya-Wiltshire, Christine, von Braun, Amrei, Lamorde, Mohammed, Ledergerber, Bruno, Buzibye, Allan, Henning, Lars, Musaazi, Joseph, Gutteck, Ursula, Denti, Paolo, de Kock, Miné, Jetter, Alexander, Byakika-Kibwika, Pauline, Eberhard, Nadia, Matovu, Joshua, Joloba, Moses, Muller, Daniel, Manabe, Yukari C, Kamya, Moses R, Corti, Natascia, Kambugu, Andrew, Castelnuovo, Barbara, Fehr, Jan S

“…Abstract Background The relationship between concentrations of antituberculosis drugs, sputum culture conversion, and treatment outcome remains unclear. We…”
Get full text

Effect of patient genetics on etonogestrel pharmacokinetics when combined with efavirenz or nevirapine ART by Neary, Megan, Chappell, Catherine A, Scarsi, Kimberly K, Nakalema, Shadia, Matovu, Joshua, Achilles, Sharon L, Chen, Beatrice A, Siccardi, Marco, Owen, Andrew, Lamorde, Mohammed

“…Abstract Background We previously demonstrated that etonogestrel concentrations were 82% lower in women using etonogestrel contraceptive implants plus…”
Get full text

MicroRNA‐122 and cytokeratin‐18 have potential as a biomarkers of drug‐induced liver injury in European and African patients on treatment for mycobacterial infection by Rupprechter, Sarah A.E., Sloan, Derek J., Oosthuyzen, Wilna, Bachmann, Till T., Hill, Adam T., Dhaliwal, Kevin, Templeton, Kate, Matovu, Joshua, Sekaggya‐Wiltshire, Christine, Dear, James W.

“…Aims Patients on antituberculosis (anti‐TB) therapy are at risk of drug‐induced liver injury (DILI). MicroRNA‐122 (miR‐122) and cytokeratin‐18 (K18) are DILI…”
Get full text